• Research news
    • Healthcare
      • Biosystems
      • Diagnostics
      • Disease prevention
      • Regenerative medicine
      • Therapeutics
    • Sustainability
      • Energy
      • Environment
      • Food and water
    • Technology
      • Intelligent systems and robotics
      • Biotechnology
      • Electronics
      • Manufacturing
      • Micro-/nanotechnology
      • Optics
      • Sensors
    • Basic research
      • Astronomy
      • Chemistry
      • Life science
      • Physics
      • Polymer science
  • Explainers
  • COVID-19
  • Features
  • Commentary
  • About us
  • 中国
Features | Therapeutics

Cholera Toxin Converted to Potential Anti-Glioma Agent

by Ekaterina Perets | Sep 21, 2017

A multifunctional targeting of intracranial glioma inspired by the intoxication mechanism of the Cholera toxin is demonstrated.

Glioma is one of the most malignant central nervous system cancers and is rarely curable. The current treatment options are limited to surgery in combination with radiation therapy and/or chemotherapy. Due to the location of the tumor, either in the brain or spine, it is not surprising that these treatments carry significant risks and often result in severe side-effects.

Targeted drug delivery for cancer treatment promises reduced side-effects and higher efficiency by using nanocarriers  that deliver the drug directly to the tumor site. Targeted therapy has been successfully implemented in the treatment of many types of cancer such as breast, colon, lung and others. For the treatment of brain cancer however, this type of therapy is problematic, mainly due to the virtual impermeability of the Blood-Brain-Barrier (BBB) which prevents more than 98% of small molecules administered to the patient from reaching the brain.

To tackle this issue, researchers have used two or more ligands to modify the nanocarriers in order to escape the strict BBB selection, by preventing their deactivation by the digestive enzymes. However, this type of modification has several drawbacks. First, it makes the preparation process very complicated. Second, it is unknown whether the different ligands interfere with each other, thus reducing the overall activity. Also, in the recent years, proteins (and protein-like molecules) have been widely used as targeting ligands. However, when these molecules are modified on the surface of nanocarriers, they will thoroughly interact with plasma proteins (as well as enzymes). It is very common that the plasma proteins coat the nanocarrier surface or that the enzymes digest the targeting molecules, thus inducing the deactivation of the ligands. Therefore, the goal is to achieve multifunctional glioma-targeted drug delivery and to ensure that the targeting molecules are still bioactive in vivo.

In a recently published article in Advanced Healtcare Materials, scientists from China demonstrate a multifunctional targeting of intracranial glioma inspired by the intoxication mechanism of the Cholera toxin. The PLGA nanoparticles modified with the toxin (CTB-NPs) are shown to successfully penetrate the BBB in-vitro and effectively target glioma cells and neovasculature. In addition, the stability of cholera toxin subunit B in plasma, as well as the protein components of the protein corona (plasma proteins coating on the nanocarrier surface), are thoroughly studied in vivo, and the results indicate that the attached targeting ligand is still active.

Furthermore, when loaded with the chemotherapeutic drug, Paclitaxel,  these targeting nanoparticles (CTB-NP/PTX) induce cell death of glioma cells and remove neovasulature in mice with glioma, resulting in prolonged survival.

The overreaching impact of this study is providing a single protein that can achieve multifunctional targeting of glioma for drug delivery. Future studies will focus on the safety and efficacy, such as  immunogenicity assessment, in larger animals and humans.

Related posts:

The Promise and Challenges of Nanomedicines in Fighting Cancer
Eco-friendly glue sticks to the basics
The three colors of hydrogen
Engineering Natural Killer Cells for Cancer Immunotherapy [Video]

Popular

  • Astronomers estimate there are 36 communicating civilizations in our galaxy
  • Never say never – Seeing the birth of a crystal
  • Can the pneumonia vaccine protect against COVID-19?
  • Lessons learned during the COVID-19 pandemic
  • Diamonds created in minutes at room temperature
  • Maybe life on Earth is as good as it gets?
  • Teleportation is possible, it just depends on scale
  • A new material brings scientists closer to a “quantum brain”
  • how gluten affects the gut Changing gluten intake found to have no impact on gut inflammation in healthy individuals
  • Improving Li-ion battery performance using 3D printing

Explainer

  • About us
  • Newsletter
  • Advertising & Marketing
  • Wiley Online Library
  • Privacy
  • Impressum
  • Facebook
  • Twitter
Copyright © 1999-2020 John Wiley & Sons, Inc. All rights reserved.
Our site uses cookies to improve your experience. You can find out more about our use of cookies in our standard cookie policy, including instructions on how to reject and delete cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in our standard cookie policy. Close
Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.

SAVE & ACCEPT